Safe Handling of Cytotoxic Compounds in a Biopharmaceutical Environment-Reference-Cited by-同舟云学术

Safe Handling of Cytotoxic Compounds in a Biopharmaceutical Environment

Published:2013 Issue: Volume: Page:133-143
ISSN:1064-3745
Container-title:Methods in Molecular Biology
language:
Short-container-title:

Author:

Hensgen Miriam I.,Stump Bernhard

Publisher

Humana Press

Link

http://link.springer.com/content/pdf/10.1007/978-1-62703-541-5_8

Reference19 articles.

1. Harris CC (1976) The carcinogenicity of anticancer drugs: a hazard in man. Cancer 37:1014–1023

2. Hughes B (2010) Antibody–drug conjugates for cancer: poised to deliver? Nat Rev Drug Discov 9:665–667

3. Axon MW, Farris JP, Mason J (2008) Handling highly potent active pharmaceutical ingredients. Chem Today 26:57–61

4. Thayer AM (2008) Contained chemistry. Synthesizing highly potent compounds is a lucrative and growing niche for custom chemical manufacturers. Chem Eng News 86:17–27

5. Rohrer T (2010) Challenges in the manufacturing of antibody drug conjugates. Innovat Pharmaceut Tech 10–12 http://www.iptonline.com/articles/public/p10-12%20non-print.pdf

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Quality Assurance in Safe Handling of Hazardous Drugs Among Healthcare Workers in KSA: A Scoping Review;Pakistan BioMedical Journal;2024-02-29

2. How Process Enabling Closed Systems Offer Maximum Safety in ADC Manufacturing;ADC Review / Journal of Antibody-drug Conjugates;2023-06-19

3. Simplified strategy for developing purification processes for antibody-drug conjugates using cation-exchange chromatography in flow-through mode;Journal of Chromatography A;2022-03

4. Progress in the Development of Single‐Use Solutions in Antibody–Drug Conjugate (ADC) Manufacturing;Single‐Use Technology in Biopharmaceutical Manufacture;2019-07-26

5. Unconventional Fragment Usage Enables a Concise Total Synthesis of (−)-Callyspongiolide;Journal of the American Chemical Society;2018-01-19